Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIAMOND: Advagraf Dosing Regimens in Liver Transplant
NCT01011205Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2009
- Primary completion
- Jan 2013
- Modality
- Orthosteric Ligands
- Countries
- 23
01
Overview
A Phase 3 trial of tacrolimus + Wuzhi capsule in Liver transplant rejection, sponsored by Astellas Pharma. Started Sep 2009; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT01011205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01011205.